Soleus Capital Master Fund, L.P. 13D and 13G filings for AxoGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-02 5:00 pm Sale |
2025-03-31 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 1,446,117 3.700% |
-1,559,826 (-51.89%) |
Filing |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 3,005,943 6.800% |
410,128 (+15.80%) |
Filing |
| 2024-02-02 09:29 am Sale |
2023-12-31 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 2,595,815 6.000% |
-945,483 (-26.70%) |
Filing |
| 2023-08-11 4:31 pm Purchase |
2023-08-08 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 3,541,298 8.200% |
3,541,298 (New Position) |
Filing |